Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
Recent trials of intensive glycemic control suggest a possible link between hypoglycemia and excess cardiovascular mortality in patients with type 2 diabetes. Hypoglycemia might cause arrhythmias through effects on cardiac repolarization and changes in cardiac autonomic activity. Our aim was to study the risk of arrhythmias during spontaneous hypoglycemia in type 2 diabetic patients with cardiovascular risk. Twenty-five insulin-treated patients with type 2 diabetes and a history of cardiovascular disease or two or more risk factors underwent simultaneous continuous interstitial glucose and ambulatory electrocardiogram monitoring. Frequency of arrhythmias, heart rate variability, and markers of cardiac repolarization were compared between hypoglycemia and euglycemia and between hyperglycemia and euglycemia matched for time of day. There were 134 h of recording at hypoglycemia, 65 h at hyperglycemia, and 1,258 h at euglycemia. Bradycardia and atrial and ventricular ectopic counts were significantly higher during nocturnal hypoglycemia compared with euglycemia. Arrhythmias were more frequent during nocturnal versus daytime hypoglycemia. Excessive compensatory vagal activation after the counterregulatory phase may account for bradycardia and associated arrhythmias. QT intervals, corrected for heart rate, >500 ms and abnormal T-wave morphology were observed during hypoglycemia in some participants. Hypoglycemia, frequently asymptomatic and prolonged, may increase the risk of arrhythmias in patients with type 2 diabetes and high cardiovascular risk. This is a plausible mechanism that could contribute to increased cardiovascular mortality during intensive glycemic therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational reports in individuals with diabetes undergoing continuous glucose and electrocardiogram (ECG) monitoring have noted an increased prevalence of arrhythmias during periods of hypoglycemia as compared to euglycemia (5, 6).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [5]
In the citing paper
“They can also be vulnerable to irregular heartbeat, which can be life-threatening45.”
From A wearable patch for continuous analysis of thermoregulatory sweat at rest (2021) · cites this paper as [45]
In the citing paper
“In contrast, patients with diabetes may have a lower risk of inappropriate therapy or ICD shock, since they may be more sedentary with consequently less frequent exercise-induced sinus tachycardia and also lower incidence of lead fracture.600,658,659”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [658]
In the citing paper
“Observational studies have reported significant corrected QT (QTc) interval prolongation possibly associated with microvascular complications, atypical patterns of microvolt T-wave alternans, altered heart rate variability, or heart rate turbulence in patients with diabetes, but none of these tests should routinely be used to stratify the risk of ventricular arrhythmias or SCD in clinical practice”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [658]
Citations
Cites
Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use
Electrophysiology, T. F. O. T. E. S. O. C. T. N. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.1043 · Cited by 17,159
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., & Schwartz, P. J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014868 · Cited by 15,289
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“Intensive glycemic control for between 3 and 5 years did not reduce cardiovascular mortality in recent trials (2,3) and the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was terminated early owing to increased mortality in patients with type 2 diabetes at high cardiovascular risk (4).”
BackgroundTesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Cardiac Electrophysiology: From Cell to Bedside
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-12-1069_5 · Cited by 2,385
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Self-citationDiagnosis and management of diabetic autonomic neuropathy.
Ewing, D. J., & Clarke, B. F. (1982) · BMJ · doi:10.1136/bmj.285.6346.916 · Cited by 1,235
Montano, N., Ruscone, T. G., Porta, A., Lombardi, F., Pagani, M., & Malliani, A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1826 · Cited by 1,108
Cited by
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Differentiation of diabetes by pathophysiology, natural history, and prognosis
Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Groop, P.-H., Handelsman, Y., Insel, R. A., Mathieu, C., et al. (2017) · Diabetes · doi:10.2337/db16-0806 · Cited by 823
“Hypoglycemia is linked to arrhythmias and mortality in people with a history of cardiovascular events (145).”
BackgroundInternational Hypoglycaemia Study Group (2017) · Diabetes Care · doi:10.2337/dc16-2215 · Cited by 608
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563
Amiel, S. A., Aschner, P., Childs, B., Cryer, P. E., de Galan, B. E., Frier, B. M., Gonder-Frederick, L., Heller, S. R., Jones, T., Khunti, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30315-2 · Cited by 526
Self-citationHypoglycaemia in diabetes mellitus: epidemiology and clinical implications
Frier, B. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.170 · Cited by 481
A wearable patch for continuous analysis of thermoregulatory sweat at rest
Nyein, H. Y. Y., Bariya, M., Tran, B., Ahn, C. H., Brown, B. J., Ji, W., Davis, N., & Javey, A. (2021) · Nature Communications · doi:10.1038/s41467-021-22109-z · Cited by 437
Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences
Gallo, L. A., Wright, E. M., & Vallon, V. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114561992 · Cited by 395
The International Hypoglycaemia Study Group (2017) · Diabetologia · doi:10.1007/s00125-016-4146-6 · Cited by 360
“both glucose concentrations were associated with cardiac arrhythmias [19, 20].”
Background(2015) · doi:10.1136/bmj.h3234 · Cited by 258
Lee, A. K., Warren, B., Lee, C. J., McEvoy, J. W., Matsushita, K., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetes Care · doi:10.2337/dc17-1669 · Cited by 226
“In addition, the activated sympathetic nervous system leads to hypokalemia in the myocardium, potentially causing arrhythmias (13,14).”
The consequences of hypoglycaemia
Amiel, S. A. (2021) · Diabetologia · doi:10.1007/s00125-020-05366-3 · Cited by 223
“Cardiovascular consequences Other potential acute consequences of hypoglycaemic episodes include cardiovascular effects, both as a result of the stress response (tachycardia, widened arterial pulse pressure) and arrythmias [23, 24], including lengthening of the QT interval (QTc) on an electrocardiogram and bradycardia.”
BackgroundComparative review of dipeptidyl peptidase‐4 inhibitors and sulphonylureas
Deacon, C. F., & Lebovitz, H. E. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12610 · Cited by 213
Minimizing Hypoglycemia in Diabetes
International Hypoglycaemia Study Group (2015) · Diabetes Care · doi:10.2337/dc15-0279 · Cited by 209
Lane, W., Bailey, T. S., Gerety, G., Gumprecht, J., Philis-Tsimikas, A., Hansen, C. T., Nielsen, T. S. S., Warren, M., Group Information, & 1, T. S. (2017) · JAMA · doi:10.1001/jama.2017.7115 · Cited by 206
Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
Saisho, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018381 · Cited by 195
“lead to a sudden death, so called “dead-in-bed” syndrome [71–75].”
BackgroundPorumb, M., Stranges, S., Pescapè, A., & Pecchia, L. (2020) · Scientific Reports · doi:10.1038/s41598-019-56927-5 · Cited by 196
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0255-6 · Cited by 188
“However, both the ADA and the European Association for the Study of Diabetes (EASD) consider glucose levels below 3 mmol/L (54 mg/dL) as serious and clinically important [13] due to the associated risks of cardiac arrhythmias [14, 15] and mortality in type 2 diabetes [16, 17].”
Lee, C. J., Clark, J. M., Schweitzer, M., Magnuson, T., Steele, K., Koerner, O., & Brown, T. T. (2015) · Obesity · doi:10.1002/oby.21042 · Cited by 159
Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes
Grisanti, L. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01669 · Cited by 174
“In a separate but similar study, type 2 diabetic patients with a history or risk of cardiovascular disease were monitored for interstitial glucose and ambulatory electrocardiogram simultaneously (Chow et al., 2014).”
BackgroundDEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
on behalf of the DEVOTE Study Group, Pieber, T. R., Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pratley, R. E., Woo, V. C., Heller, S. R., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4422-0 · Cited by 160
“5 mmol/l) was common, occurring 6% of the time [28].”
BackgroundSelf-citationCaMKII signaling in heart diseases: Emerging role in diabetic cardiomyopathy
Hegyi, B., Bers, D. M., & Bossuyt, J. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.01.001 · Cited by 156
Kemps, H., Kränkel, N., Dörr, M., Moholdt, T., Wilhelm, M., Paneni, F., Serratosa, L., Ekker Solberg, E., Hansen, D., Halle, M., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487318820420 · Cited by 144
Bell, D. S. H., & Gonçalves, E. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13512 · Cited by 156
“This points to hypoglycaemia as being a major contributor to the development of NAF, as has been shown in other studies.(32,69,70) Almost all GLP-1 agonists modestly increase the heart rate, which could be interpreted as the result of stimulation of the sympathetic”
ResultWinkley, K., Upsher, R. J., Stahl, D. R., Pollard, D. J., Kasera, A., Brennan, A., Heller, S. R., & Ismail, K. (2020) · Health Technology Assessment · doi:10.3310/hta24280 · Cited by 197
Self-citationThe FLAT-SUGAR Trial Investigators (2016) · Diabetes Care · doi:10.2337/dc15-2782 · Cited by 135
“Furthermore, hypoglycemia is strongly associated with GV and may promote cardiac arrhythmias (10) while limiting the ability of insulin therapy to attain desired levels of control of A1C.”
BackgroundHypoglycemia and Cardiovascular Risk: Is There a Major Link?
Hanefeld, M., Frier, B. M., & Pistrosch, F. (2016) · Diabetes Care · doi:10.2337/dcs15-3014 · Cited by 135
“(36), where bradycardia and ventricular ectopics were strongly associated with nocturnal rather than daytime hypoglycemia and may reflect the obtunded sympatho-”
BackgroundFortmann, A. L., Bagsic, S. R. S., Talavera, L., Garcia, I. M., Sandoval, H., Hottinger, A., & Philis‐Tsimikas, A. (2020) · Diabetes Care · doi:10.2337/dc20-1016 · Cited by 127
Ding, L., Zhang, H., Dai, C., Zhang, A., Yu, F., Mi, L., Qi, Y., & Tang, M. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02172-8 · Cited by 138
“…with type 2 diabetes with cardiovascular risk, a heart rate-corrected QT interval, > 500ms and abnormal T-waves were observed during hypoglycemia [43]; (3) Causing the activation of the sympatho-adrenal system: acute hypoglycemia causes a pronounced physiological response, releases the…”
BackgroundRole of continuous glucose monitoring for type 2 in diabetes management and research
Vigersky, R. A., & Shrivastav, M. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.007 · Cited by 126
Novodvorsky, P., Bernjak, A., Chow, E., Iqbal, A., Sellors, L., Williams, S., Fawdry, R. A., Parekh, B., Jacques, R. M., Marques, J. L. B., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2177 · Cited by 111
“We reported similar findings in an ambulatory study in type 2 diabetes (21).”
BackgroundResultInfluentialWe Can Change the Natural History of Type 2 Diabetes
Phillips, L. S., Ratner, R. E., Buse, J. B., & Kahn, S. E. (2014) · Diabetes Care · doi:10.2337/dc14-0817 · Cited by 114
“dently associated with QTc interval prolongation in both type 2 and type 1 diabetes (17,19), and there are plausible biological mechanisms through which hy-”
BackgroundColom, C., Rull, A., Sánchez‐Quesada, J. L., & Pérez, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081798 · Cited by 118
Perioperative management of hyperglycemia and diabetes in cardiac surgery patients
Galindo, R. J., Fayfman, M., & Umpierrez, G. E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.005 · Cited by 95
Van Wagoner, D. R., Piccini, J. P., Albert, C. M., Anderson, M. E., Benjamin, E. J., Brundel, B., Califf, R. M., Calkins, H., Chen, P.-S., Chiamvimonvat, N., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2014.11.011 · Cited by 94
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes Mellitus
Kirkman, M. S., Mahmud, H., & Korytkowski, M. T. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.002 · Cited by 95
Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management
Eleftheriadou, A., Spallone, V., Tahrani, A. A., & Alam, U. (2024) · Diabetologia · doi:10.1007/s00125-024-06242-0 · Cited by 122
Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management
Williams, S., Raheim, S. A., Khan, M. I., Rubab, U., Kanagala, P., Zhao, S. S., Worthington, A., Brown, E. E., & Alam, U. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.09.002 · Cited by 112
Self-citationEffect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans
Iqbal, A., Prince, L. R., Novodvorský, P., Bernjak, A., Thomas, M. R., Birch, L., Lambert, D., Kay, L. J., Wright, F., Macdonald, I. A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01168 · Cited by 97
Self-citationDiabetes Mellitus and Acute Myocardial Infarction: Impact on Short and Long-Term Mortality
Milazzo, V., Cosentino, N., Genovese, S., Campodonico, J., Mazza, M., Metrio, M. D., & Marenzi, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_481 · Cited by 98
Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
Tsujimoto, T., Sugiyama, T., Shapiro, M. F., Noda, M., & Kajio, H. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09259 · Cited by 81
Hyperglycemia regulates cardiac K+ channels via O-GlcNAc-CaMKII and NOX2-ROS-PKC pathways
Hegyi, B., Borst, J. M., Bailey, L. R. J., Shen, E. Y., Lucena, A. J., Navedo, M. F., Bossuyt, J., & Bers, D. M. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-00834-8 · Cited by 81
Pistrosch, F., Ganz, X., Bornstein, S. R., Birkenfeld, A. L., Henkel, E., & Hanefeld, M. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0727-y · Cited by 83
Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus
Yun, J., & Ko, S. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.6.423 · Cited by 83
“The report that ectopic beats were particularly prominent during the night when the participants were asleep is evidence to suggest that we take care of these patients to avoid hypoglycemia at night in patients undergoing diabetes care [49].”
BackgroundLong, C. A., Fang, Z. B., Hu, F. Y., Arya, S., Brewster, L. P., Duggan, E. W., & Duwayri, Y. M. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.06.212 · Cited by 78
Holden, S. E., Jenkins‐Jones, S., Morgan, C. L., Schernthaner, G.-H., & Currie, C. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12412 · Cited by 78
Scheen, M., Giraud, R., & Bendjelid, K. (2021) · Physiological Reports · doi:10.14814/phy2.14713 · Cited by 98
“Cardiac performance is directly impacted by both hyperglycemia and hypoglycemia, the latter being associated with an increased adrenergic tone that favors recurrent myocardial ischemia and the development of triggered ventricular arrhythmias (Chow et al., 2014; Zhang & Zhou, 2016).”
BackgroundThe risks of nocturnal hypoglycaemia in insulin-treated diabetes
Graveling, A. J., & Frier, B. M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.012 · Cited by 85
Lee, C. J., Wood, G. C., Lazo, M., Brown, T. T., Clark, J. M., Still, C. D., & Benotti, P. N. (2016) · Obesity · doi:10.1002/oby.21479 · Cited by 72
Shen, L., Rørth, R., Cosmi, D., Kristensen, S. L., Petrie, M. C., Cosmi, F., Latini, R., Køber, L., Anand, I. S., Carson, P. E., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1535 · Cited by 71
Bahrmann, A., Bahrmann, P., Baumann, J., Bauer, J. M., Brückel, E., Dreyer, M., Freitag, M., Friedl, A., Gölz, S., Grundke, S., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0666-0820 · Cited by 71
Spanakis, E. K., Levitt, D. L., Siddiqui, T., Singh, L. G., Pinault, L. F., Sorkin, J. D., Umpierrez, G. E., & Fink, J. C. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817748964 · Cited by 75
BAJAJ, H. S., Venn, K., Ye, C., Patrick, A., Kalra, S., Khandwala, H. M., Aslam, N., Twum-Barima, D., & Aronson, R. (2016) · Diabetes Care · doi:10.2337/dc16-1582 · Cited by 65
Chow, E., Bernjak, A., Walkinshaw, E., Lubina-Solomon, A., Freeman, J., Macdonald, I. A., Sheridan, P. J., & Heller, S. R. (2017) · Diabetes · doi:10.2337/db16-1310 · Cited by 63
Self-citationKo, S., Park, Y., Yun, J., Cha, S., Choi, E., Han, K., Han, E., Lee, Y., & Ahn, Y. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.09.009 · Cited by 70
Tharakan, G., Behary, P., Albrechtsen, N. J. W., Chahal, H., Kenkre, J. S., Miras, A. D., Ahmed, A., Holst, J. J., Bloom, S. R., & Tan, T. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0446 · Cited by 66
Effects of Hypoglycemia on Cardiovascular Function in Patients with Diabetes
Christou, M., Christou, P. A., Kyriakopoulos, C., Christou, G. A., & Tigas, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119357 · Cited by 71
Hayashi, A., Shimizu, N., Suzuki, A., Matoba, K., Momozono, A., Masaki, T., Ogawa, A., Moriguchi, I., Takano, K., Kobayashi, N., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0269 · Cited by 65
Heller, S. R., Bergenstal, R. M., White, W. B., Kupfer, S., Bakris, G. L., Cushman, W. C., Mehta, C. R., Nissen, S. E., Wilson, C., Zannad, F. M., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12871 · Cited by 57
Self-citationIqbal, A., & Heller, S. R. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.004 · Cited by 64
“These events appeared to be precipitated by nocturnal hypoglycaemic episodes with bradycardia, atrial and ventricular ectopics occurring more frequently at night (71).”
BackgroundSelf-citationFitzpatrick, C., Chatterjee, S., Seidu, S., Bodicoat, D. H., Ng, G. A., Davies, M. J., & Khunti, K. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13348 · Cited by 57
“In total, 7 studies assessed the occurrence of CA.(22,23,31,35,41,44,45) Of these, 1 reported no incidence(3) and 2 reported the occurrence of ventricular premature beats (VPB) across both glycaemic conditions.”
BackgroundResultInfluentialOstropolets, A., Elias, P. A., Reyes, M. V., Wan, E. Y., Pajvani, U. B., Hripcsak, G. M., & Morrow, J. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009115 · Cited by 60
Klimontov, V. V., & Myakina, N. E. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.08.023 · Cited by 59
Seaquist, E. R., Dulude, H., Zhang, X. M., RABASA-LHORET, R. P. R., Tsoukas, G. M., Conway, J. R., Weisnagel, S. J., Gerety, G., Woo, V. C., Zhang, S., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13278 · Cited by 54
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance
Caturano, A., Galiero, R., Vetrano, E., Sardu, C., Rinaldi, L., Russo, V., Monda, M., Marfella, R., & Sasso, F. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158369 · Cited by 63
“This risk underscores the need for careful monitoring and management of blood glucose levels to prevent hypoglycemic episodes [243,244].”
BackgroundFranek, E., Haluzík, M., Canecki Varžić, S., Sargin, M., Macura, S., Zacho, J., & Christiansen, J. S. (2016) · Diabetic Medicine · doi:10.1111/dme.12982 · Cited by 51
Hypoglycemia: New Definitions and Regulatory Implications
Ratner, R. E. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0113 · Cited by 57
“11 It is very apparent, however, that hypoglycemic events short of loss of consciousness or requiring the assistance of Division of Endocrinology, Diabetes, and Metabolism, Georgetown University School of Medicine, Washington, District of Columbia. a third party have significant impact on patient…”
Lee, C. J., Brown, T. T., Schweitzer, M., Magnuson, T., & Clark, J. M. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.01.028 · Cited by 49
Kodama, S., Fujihara, K., Shiozaki, H., Horikawa, C., Yamada, M. H., Sato, T., Yaguchi, Y., Yamamoto, M., Kitazawa, M., Iwanaga, M., et al. (2021) · JMIR Diabetes · doi:10.2196/22458 · Cited by 49
“For example, for patients with both DM and high cardiovascular risk, in particular, those who are vulnerable to cardiac arrhythmias, using ECGs for detecting hypoglycemia is useful considering that a hypoglycemia-induced arrhythmia could contribute to increased cardiovascular mortality [57].”
BackgroundKranenburg, G., van der Graaf, Y., van der Leeuw, J., Nathoe, H. M., de Borst, G. J., Kappelle, L. J., Visseren, F. L. J., & Westerink, J. (2015) · Diabetes Care · doi:10.2337/dc15-0493 · Cited by 57
“Oral anticoagulants 14 (160) 4 (23) ,0.”
BackgroundKobayashi, S., Nagao, M., Asai, A., Fukuda, I., Oikawa, S., & Sugihara, H. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12772 · Cited by 50
Risk Factors for Spontaneously Self-Reported Postprandial Hypoglycemia After Bariatric Surgery
Nannipieri, M., Belligoli, A., Guarino, D., Busetto, L., Moriconi, D., Fabris, R., Mari, A., Baldi, S., Anselmino, M., Foletto, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1143 · Cited by 47
Hypoglycaemia and cardiac arrhythmias in diabetes
Andersen, A., Jørgensen, P. G., Knop, F. K., & Vilsbøll, T. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820911803 · Cited by 54
Metabolic Dysfunction in Hutchinson–Gilford Progeria Syndrome
Kreienkamp, R., & Gonzalo, S. (2020) · Cells · doi:10.3390/cells9020395 · Cited by 45
“In fact, previous studies have shown that hypoglycemia can increase the QTc interval [78,79].”
BackgroundAndersen, A., Bagger, J. I., Sørensen, S. K., BALDASSARRE, M. P. A., Pedersen‐Bjergaard, U., Forman, J. L., Gislason, G., Lindhardt, T. B., Knop, F. K., & Vilsbøll, T. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01425-0 · Cited by 48
Han, K., Yun, J., Park, Y., Ahn, Y., Cho, J., Cha, S., & Ko, S. (2018) · Clinical Epidemiology · doi:10.2147/clep.s169835 · Cited by 53
“Due to the limitation of the claims DB, from which glucose concentrations during SH events could not be confirmed, we used the ICD-10 codes for SH (E16.x, E11.”
BackgroundGorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43
Hypoglycemia-Associated Autonomic Failure in Diabetes: Maladaptive, Adaptive, or Both?
Cryer, P. E. (2015) · Diabetes · doi:10.2337/db15-0331 · Cited by 43
Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., & Kollman, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0362 · Cited by 42
Glucose Variability and Coronary Artery Disease
Xia, J., & Yin, C. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.10.019 · Cited by 44
Zaccardi, F., Dhalwani, N. N., Webb, D. R., Davies, M. J., & Khunti, K. (2018) · Diabetologia · doi:10.1007/s00125-018-4626-y · Cited by 45
Basal fatty acid oxidation increases after recurrent low glucose in human primary astrocytes
Potter, P. G. W., Walker, J. M. V., Robb, J. L., Chilton, J. K., Williamson, R., Randall, A. D., Ellacott, K. L. J., & Beall, C. (2018) · Diabetologia · doi:10.1007/s00125-018-4744-6 · Cited by 45
Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes
Yun, J., & Ko, S. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.1.6 · Cited by 43
“Hypoglycemia changed cardiac repolarization and induced arrhythmias in patients with type 1 and type 2 diabetes [49-51].”
BackgroundLin, Y. K., Richardson, C. R., Dobrin, I., DeJonckheere, M. J., Mizokami-Stout, K., Fetters, M. D., Aikens, J. E., Fisher, S. J., Ye, W., & Pop-Busui, R. (2022) · Diabetes Care · doi:10.2337/dc21-1285 · Cited by 40
The FLAT-SUGAR Trial Investigators (2015) · Diabetes Care · doi:10.2337/dc14-2689 · Cited by 39
Tsujimoto, T., & Kajio, H. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11408 · Cited by 38
Shimabukuro, M., Tanaka, A., Sata, M., Dai, K., Shibata, Y., Inoue, Y., Ikenaga, H., Kishimoto, S., Ogasawara, K., Takashima, A., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0571-1 · Cited by 38
Duggan, E. W., Klopman, M. A., Berry, A. J., & Umpierrez, G. E. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0720-z · Cited by 39
Cardiac Effects of Sulfonylurea-Related Hypoglycemia
Middleton, T. L., Wong, J., Molyneaux, L., Brooks, B. A., Yue, D. K., Twigg, S. M., & Wu, T. (2017) · Diabetes Care · doi:10.2337/dc16-1972 · Cited by 38
Insulin and Its Cardiovascular Effects: What Is the Current Evidence?
Dongerkery, S. P., Schroeder, P. R., & Shomali, M. E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0955-3 · Cited by 38
Fung, E., Lui, L.-T., Huang, L., Cheng, K. F., Lau, G. H. W., Chung, Y. T., Ahmadabadi, B. N., Xie, S., Lee, J. S. W., Hui, E., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00251-8 · Cited by 38
Self-citationQT prolongation caused by insulin-induced hypoglycaemia – An interventional study in 119 individuals
Kacheva, S., Karges, B., Göller, K., Marx, N., Mischke, K., & Karges, W. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.11.021 · Cited by 38
Conget, I., Castañeda, J., Petrovski, G., Guerci, B., Racault, A.-S., Reznik, Y., Cohen, O., Runzis, S., de Portu, S., Aronson, R., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0159 · Cited by 38
Heller, S. R., Geybels, M. S., Iqbal, A., Liu, L., Wagner, L., & Chow, E. (2021) · Diabetologia · doi:10.1007/s00125-021-05556-7 · Cited by 37
Self-citationLaguna Sanz, A. J., Mulla, C. M., Fowler, K. M., Cloutier, E., Goldfine, A. B., Newswanger, B., Cummins, M., Deshpande, S., Prestrelski, S. J., Strange, P., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0298 · Cited by 34
“Severe hypoglycemia can result in syncope, falls, and seizures, and hypoglycemia can cause cardiac arrhythmias.(23,24) Hypoglycemia occurring multiple times per day can lead to hypoglycemic unawareness, reducing safety in driving and employment, reducing autonomy, and causing fear of eating and activity.”
Østergaard, H. B., Mandrup-Poulsen, T. R., Berkelmans, G. F. N., van der Graaf, Y., Visseren, F. L. J., & Westerink, J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.04.006 · Cited by 33
Clinical features and therapeutic perspectives on hypertension in diabetics
Katayama, S., Hatano, M., & Issiki, M. (2018) · Hypertension Research · doi:10.1038/s41440-017-0001-5 · Cited by 39
“underwent continuous glucose monitoring (CGM) and Holter ECG measurements [41].”
MethodPorumb, M., Griffen, C., Hattersley, J. G., & Pecchia, L. (2020) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2020.102054 · Cited by 36
Fujiki, S., Iijima, K., Nakagawa, Y., Takahashi, K., Okabe, M., KUSANO, K. F., Owada, S., Kondo, Y., Tsujita, K., Shimizu, W., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02309-9 · Cited by 39
Metadata
- Authors
- Chow, E., Bernjak, A., Williams, S., Fawdry, R. A., Hibbert, S., Freeman, J., Sheridan, P. J., & Heller, S. R.
- Affiliations
- University of Sheffield (GB)
- Corresponding author
- Heller, Simon R.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-04-12
- Volume
- 63
- Issue
- 5
- Pages
- 1738-1747
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2042767418
- Cited by
- 403
- References
- 46
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 19 · 2023: 25 · 2022: 30 · 2021: 40 · 2020: 33 · 2019: 25 · 2018: 51 · 2017: 40 · 2016: 41 · 2015: 44 · 2014: 8
- FWCI
- 35.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0611-10248, ACF-2008-04-002, BRF-2011-004)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypoglycemia, cardiac arrhythmias, type 2 diabetes, cardiovascular risk, nocturnal hypoglycemia, bradycardia, cardiac repolarization, QT interval, heart rate variability, insulin-treated patients, cardiovascular mortality, tight glycemic control, Holter monitoring
- MeSH terms
- Aged, Arrhythmias, Cardiac, Autonomic Nervous System, Blood Glucose, Diabetes Mellitus, Type 2, Female, Heart, Heart Rate, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Middle Aged, Risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.